Press Releases

All Releases
View Summary MannKind Corporation Reports 2017 Third Quarter Financial Results
11/07/17
PDF 27.7 KB Add to Briefcase
View Summary MannKind Corporation to Hold 2017 Third Quarter Financial Results Conference Call on November 7, 2017
10/27/17
PDF 9.4 KB Add to Briefcase
View Summary MannKind Restructures Near-Term Debt Obligations
10/23/17
PDF 14.7 KB Add to Briefcase
View Summary MannKind and BIOMM Submit Registration Dossier to Brazilian Health Regulatory Agency (ANVISA)
10/23/17
PDF 12.7 KB Add to Briefcase
View Summary MannKind Donates Afrezza® to Support People with Diabetes Impacted by Hurricane Maria in Puerto Rico
10/12/17
PDF 10.8 KB Add to Briefcase
View Summary MannKind Announces $61 Million Registered Direct Offering of Common Stock
10/11/17
PDF 15.8 KB Add to Briefcase
  FDA Updates Afrezza® Prescribing Information
10/02/17
PDF 597.9 KB Add to Briefcase
View Summary MannKind Corporation to Hold Investor Conference Call
10/01/17
PDF 9.6 KB Add to Briefcase
View Summary MannKind Responds to Hurricane Harvey Devastation with Afrezza® Donation
09/07/17
PDF 9.4 KB Add to Briefcase
View Summary MannKind Corporation Relocates Headquarters to Westlake Village
09/05/17
PDF 9.4 KB Add to Briefcase
View Summary MannKind Corporation to Present at Upcoming Conferences
09/01/17
PDF 10.4 KB Add to Briefcase
  MannKind Corporation Reports 2017 Second Quarter Financial Results
08/07/17
PDF 201.7 KB Add to Briefcase
View Summary MannKind and One Drop Partner to Launch the A-ONE Clinical Trial
08/07/17
PDF 19.9 KB Add to Briefcase
View Summary MannKind Corporation to Hold 2017 Second Quarter Financial Results Conference Call on August 7, 2017
07/25/17
PDF 8.8 KB Add to Briefcase
View Summary Steven Binder Joins MannKind as Chief Financial Officer
07/17/17
PDF 10.5 KB Add to Briefcase
View Summary Patrick McCauley Joins MannKind as Chief Commercial Officer
07/12/17
PDF 10.0 KB Add to Briefcase
View Summary MannKind Renegotiates Near-Term Maturities with Deerfield
06/29/17
PDF 10.6 KB Add to Briefcase
View Summary MannKind Draws Remaining Funds under Mann Group Loan Arrangement
06/29/17
PDF 10.3 KB Add to Briefcase
View Summary MannKind Engages Locust Walk to Explore Strategic Options for MannKind's Non-insulin Technosphere-based Pipeline Candidates
06/05/17
PDF 10.5 KB Add to Briefcase
View Summary MannKind and Biomm Enter Into Distribution Agreement for Afrezza in Brazil
05/31/17
PDF 11.3 KB Add to Briefcase
Showing 1-20 of 315 Page: 1 2 3 4 5 ... 16  Next 20
Add to Briefcase = add release to Briefcase

MNKD

Exchange:
NASDAQ GM (US Dollar)

Price: 2.97

Change: 0.05 (1.656%)

Volume: 2,407,198

Data as of
12/14/2017 04:00 PM ET .
Minimum 20 minute delay.

Refresh Quote >

Locations

Learn more about MannKind's offices in the United States

Learn More